Cleared Traditional

K022746 - STAT PROFILE CRITICAL CARE XPRESS ANALYZER

K022746 is an FDA 510(k) clearance for STAT PROFILE CRITICAL CARE XPRESS ANALYZER, manufactured by Nova Biomedical Corp.. The device is a Class 2 Chemistry device with product code CHL cleared through the Traditional 510(k) pathway after a 95-day FDA review.

K022746 · Nova Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2002
Decision
95d
Days
Class 2
Risk

K022746 is an FDA 510(k) clearance for the STAT PROFILE CRITICAL CARE XPRESS ANALYZER. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Nova Biomedical Corp. (Walham, US). The FDA issued a Cleared decision on November 22, 2002 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nova Biomedical Corp. devices

FDA 510(k) Submission Details - K022746

510(k) Number K022746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 2002
Decision Date November 22, 2002
Days to Decision 95 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 88d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CHL Device Classification - Class 2, Special Controls

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 157
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K022746.
ABL800 FLEX
K041874 · Radiometer Medical Aps · Oct 2004
BAYER RAPIDLAB 1200 SYSTEM
K031560 · Bayer Healthcare, LLC · Dec 2003
STAT PROFILE PHOX PLUS L ANALYZER
K023567 · Nova Biomedical Corp. · Dec 2002
STAT PROFILE PHOX PLUS C ANALYZER
K021713 · Nova Biomedical Corp. · Jul 2002
EASYSTAT PH, PCO2, PO2, HCT, NA+, K+, CA++ ANALYZER
K021515 · Medica Corp. · Jul 2002
STAT PROFILE CRITICAL CARE XPRESS ANALYZER
K020297 · Nova Biomedical Corp. · Jun 2002